Skip to main content

How much does Anoro Ellipta cost without insurance?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on March 19, 2024.

Official answer

by Drugs.com

The cost of Anoro Ellipta (umeclidinium and vilanterol) can vary between pharmacies, but there are ways to lower your costs for this medication. If you are paying the full cash price, you can look for online discount coupons that might help you lower your out-of-pockets costs. For the most up-to-date price and coupons go to the Drugs.com Price Guide.

You can view more prices and find a discount coupon here:

There is no generic option for Anoro Ellipta available in the U.S. at this time.

Does insurance pay for Anoro?

If you have private prescription insurance or Medicare Part D, your insurance may include Anoro Ellipta on their formulary and your copay cost may be much lower, depending upon which copay tier Anoro Ellipta falls under. Check with your prescription insurance company to determine your formulary coverage copay cost.

What is a drug formulary?

A formulary is a list of drugs that a benefit provider has approved, typically for one year, to be covered. You may still owe a significant portion of the cost of these medicines.

Drug tiers are typically copay amounts based on the status of the drug on the formulary. For example, generic or preferred brand drugs are usually in a lower tier (like tier 1 or 2) and have lower copays, while nonpreferred brand name drugs or biologics may be higher tier and much more costly. Nonformulary drugs may not be covered under your insurance at all, but usually there are options for these.

If your commercial insurance copay is too expensive or you have no insurance, you may be eligible for cost savings or patient assistance through GSK, the manufacturer. Programs may not be valid for any government beneficiaries including those eligible for or enrolled in Medicare or Medicaid.

Related Questions

What's in Anoro?

Anoro combines two inhaled COPD bronchodilator agents, umeclidinium bromide, a long-acting muscarinic antagonist (LAMA) and vilanterol, a long-acting beta-2 agonist (LABA).

Anoro Ellipta is used as a once-daily inhaler as a long-term treatment for chronic obstructive pulmonary disease (COPD), including bronchitis and emphysema. It is not used to treat asthma or sudden breathing problems. Do not use Anoro in combination with any other therapy containing a a long-acting beta-2 agonist (LABA) because of the risk of overdose.

This is not all the information you need to know about Anoro Ellipta and does not take the place of your doctor’s directions. Review the full patient information for your medicine and discuss any medical questions you have with your doctor, pharmacist or other health care provider.

References

Read next

Related medical questions

Drug information

Related support groups